Previous close | 0.2260 |
Open | 0.2260 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.2260 - 0.2260 |
52-week range | 0.1516 - 0.3499 |
Volume | |
Avg. volume | 59 |
Market cap | 18.065M |
Beta (5Y monthly) | 0.76 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1500 |
Earnings date | 29 Apr 2024 - 03 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), is pleased to announce the positive outcome of the shareholder vote at yesterday's special meeting (the "Meeting") of the holders ("Shareholders") of common shares in the capital of the Company ("Shares") to approve the previously announced plan of arrangement under the Business Corporations Act (Ontario) (the "Arrangement"), pursuant to which Beedie Investments Ltd. ("Beedie Capital"), will acquire all of the issued and outstan
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), is pleased to announce that it has filed and will commence mailing of the Company's management information circular dated March 1, 2024 (the "Information Circular") and related materials for the special meeting (the "Meeting") of Think shareholders ("Shareholders") to approve the previously announced plan of arrangement under the Business Corporations Act (Ontario) (the "Arrangement"), pursuant to which Beedie Investments Ltd. (
Think Research Corporation (TSXV: THNK) ("TRC" or the "Company"), a company focused on transforming healthcare through digital health software solutions, announced today that it has appointed Jeffrey Orridge to its Board of Directors. Mr. Orridge is a proven leader with a background in Software-as-a-Service ("SaaS"), Artificial Intelligence ("AI"), brand marketing, and government.